{
  "ticker": "TERN",
  "company_name": "Terns Pharmaceuticals, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT05415722",
      "title": "DUET Study: A Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy and in Combination With TERN-101 in Noncirrhotic Adults With Presumed Non-Alcoholic Steatohepatitis",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "NASH - Nonalcoholic Steatohepatitis",
      "start_date": "2022-06-28",
      "completion_date": "2023-07-10",
      "enrollment": 0,
      "sponsor": "Terns, Inc."
    },
    {
      "nct_id": "NCT06854952",
      "title": "A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Overweight or Obesity",
      "start_date": "2025-03-07",
      "completion_date": "2025-09-19",
      "enrollment": 0,
      "sponsor": "Terns, Inc."
    },
    {
      "nct_id": "NCT04897594",
      "title": "AVIATION Study: A Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TERN-201 in Patients With Non-Cirrhotic Non-Alcoholic Steatohepatitis",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "NASH - Nonalcoholic Steatohepatitis",
      "start_date": "2021-05-20",
      "completion_date": "2022-09-02",
      "enrollment": 0,
      "sponsor": "Terns, Inc."
    },
    {
      "nct_id": "NCT06163430",
      "title": "A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)",
      "status": "RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Chronic Myeloid Leukemia, Chronic Phase, Chronic Myeloid Leukemia",
      "start_date": "2024-03-26",
      "completion_date": "2030-05-31",
      "enrollment": 0,
      "sponsor": "Terns, Inc."
    },
    {
      "nct_id": "NCT04328077",
      "title": "LIFT Study: A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of TERN-101 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH)",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "NASH - Nonalcoholic Steatohepatitis",
      "start_date": "2020-06-18",
      "completion_date": "2021-05-19",
      "enrollment": 0,
      "sponsor": "Terns, Inc."
    }
  ],
  "summary": {
    "total_trials": 5,
    "by_phase": {
      "PHASE2": 3,
      "PHASE1": 1,
      "PHASE1, PHASE2": 1
    },
    "by_status": {
      "COMPLETED": 4,
      "RECRUITING": 1
    },
    "active_trials": 1,
    "completed_trials": 4,
    "conditions": [
      "Chronic Myeloid Leukemia, Chronic Phase, Chronic Myeloid Leukemia",
      "NASH - Nonalcoholic Steatohepatitis",
      "Overweight or Obesity"
    ],
    "lead_stage": "phase_2"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:22:22.248012",
    "search_query": "Terns Pharmaceuticals, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Terns+Pharmaceuticals,+Inc."
  }
}